In contrast, animals that were co‐treated with SM (ILP‐TNF/Mel/SM) were protected from tumour challenge to a greater degree, displaying prolonged survival even in a highly aggressive model (median 20 vs. 14 days, P = 0.0259, log‐rank test) (Fig 6D and E). This evidence concerns the gene XIAP and neoplasm.